In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Fintel reports that on February 11, 2025, Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with a ...

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...

Oppenheimer analysts maintained their positive stance on Cheesecake Factory (NASDAQ:CAKE) stock, reiterating an Outperform rating and a $65.00 price target. The optimism stems from a belief in the ...

Investing.com -- Oppenheimer analysts warned that Tesla (NASDAQ: TSLA) faces rising risks as competition in both electric and ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

At its current pre-market price, Tesla's stock is down 33% since hitting a record high on Dec. 18, 2024, weeks after the ...

In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...

Oppenheimer weighs in on Tesla's future amid rising AI competition and Musk's distractions. Learn about demand trends and ...

Cillian Murphy’s dedication to Oppenheimer went beyond acting—he learned 30,000 words of Dutch, followed a brutal diet, and ...

Presenters have been revealed for the 2025 Academy Awards. The first batch includes last year's lead acting winners Cillian ...

The biggest companies, those that operate in more than one state, have as much as $6 billion in debt maturing next year, ...